Many infusion patients are being switched from Remicade to one of the biosimilars. The nurses in the infusion center do not always have answers for patient/ family concerns and want to be consistent with what the GI providers are telling them. This talk will review what biosimilars are and common patient concerns around biosimilars.
Following this presentation:
The learner will define biosimilars
The learner will discuss common patient concerns around biosimilars
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.00 Attendance